<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Oncopathology</journal-id><journal-title-group><journal-title xml:lang="en">Oncopathology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкопатология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2618-7019</issn><issn publication-format="electronic">3034-3534</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">708420</article-id><article-id pub-id-type="doi">10.17650/2619-7019-2018-1-1-40-44</article-id><article-id pub-id-type="edn">ADVWTO</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Methodical materials and practical recommendations</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Методические материалы и практические рекомендации</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Morphological examination of radical prostatectomy specimens</article-title><trans-title-group xml:lang="ru"><trans-title>Особенности морфологического исследования материала радикальной простатэктомии</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kovylina</surname><given-names>M. V.</given-names></name><name xml:lang="ru"><surname>Ковылина</surname><given-names>М. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>abv@abvpress.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Prilepskaya</surname><given-names>E. A.</given-names></name><name xml:lang="ru"><surname>Прилепская</surname><given-names>Е. А.</given-names></name></name-alternatives><email>prilepskayae@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБОУВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-02-18" publication-format="electronic"><day>18</day><month>02</month><year>2018</year></pub-date><volume>1</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>40</fpage><lpage>44</lpage><history><date date-type="received" iso-8601-date="2026-06-09"><day>09</day><month>06</month><year>2026</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, ABV-Press</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, АБВ-пресс</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">ABV-Press</copyright-holder><copyright-holder xml:lang="ru">АБВ-пресс</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://oncopathology.abvpress.ru/2618-7019/about/editorialPolicies</ali:license_ref></license></permissions><self-uri xlink:href="https://oncopathology.abvpress.ru/2618-7019/article/view/708420">https://oncopathology.abvpress.ru/2618-7019/article/view/708420</self-uri><abstract xml:lang="en"><p>Radical prostatectomy (RPE) has been considered the gold standard method for the surgical treatment of localized prostate cancer, recommended by the European Association of Urologists. One of the main aims of pathologists is to obtain the maximum amount of prognostic information after RPE, which is crucialfor the prognosis and optimal treatment strategy. Therefore, it is very important to standardize surgical procedures as well as the process of morphological examination (including the system of results reporting) after RPE. The morphological report should include information on the tumor location, its spread, Gleason score, group grading, pTNM stage, presence of extraprostatic extension and the status of resection margins.</p></abstract><trans-abstract xml:lang="ru"><p>Основным методом лечения локализованного рака предстательной железы является радикальная простатэктомия (РПЭ), рекомендованная Европейской ассоциацией урологов в качестве «золотого стандарта». Одна из основных задач патологов - получение после РПЭ максимального объема прогностической информации, которая определяет прогноз и тактику ведения пациента. Поэтому очень важным становится внедрение стандартизации вырезки и морфологического заключения после РПЭ. Морфологическое заключение должно включать информацию о локализации и распространении опухоли, градации опухоли по шкале Глисона и градирующей группе, стадии по системе pTNM, наличии экстрапростатической инвазии, статусе краев резекции.</p></trans-abstract><kwd-group xml:lang="en"><kwd>prostate cancer</kwd><kwd>radical prostatectomy</kwd><kwd>standardization of morphological examination</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>рак предстательной железы</kwd><kwd>радикальная простатэктомия</kwd><kwd>стандартизация морфологического исследования</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>WHO (World Health Organization). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the urinary System and Male genital Organ. IARC Press, Lyon, France, 2016.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Srigley J.R., McGowan T., MacLean A. et al. Standardized synoptic cancer pathology reporting: a population based approach. J Surg Oncol 2009;99(8):517-24. PMID: 19466743. DOI: 10.1002/ jso.21282.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>CAP (College of American Pathologists) (2012-2013). Cancer protocols and checklists. Available at: http://www.cap.org/cancerprotocols.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>RCPA (Royal College of Pathologists of Australasia). Guidelines for Authors of Structured Cancer Pathology Reporting Protocols. RCPA, Surry Hills NSW, 2016.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>AJCC Cancer Staging Manual. 7 th edn. Eds.: S.E. Edge, D.R. Byrd, C.C.Compton et al. New York: Springer, 2010.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Kench J., Delahunt B., Griffiths D.F. et al. Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on Cancer Reporting. Histopathology 2013;62(2):203-18. PMID: 23240714. DOI: 10.1111/ his.12042.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Epstein J.I., Allsbrook W.C.J., Amin M.B., Egevad L.L. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005;29(9):1228-42. PMID: 16096414.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Samaratunga H., Montironi R., True L. et al. The ISUP Prostate Cancer Group.International Society of Urological Pa thology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. Working group 1: specimen handling. Mod Pathol 2011;24(1):16-25. PMID: 20818340. DOI: 10.1038/modpathol.2010.156.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Protocol for the examination of specimens from patients with carcinoma of the prostate gland. Version 4.0.1.0, June 2017. Includes pTNM requirements from the AJCC Staging Manual, 8 th edn. College of American Pathologists.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Amin M.B., Lin D.W., Gore J.L. et al. The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer. Arch Pathol Lab Med 2014;138(10):1387-405. PMID: 25092589. DOI: 10.5858/arpa.2014-0219-SA.</mixed-citation></ref></ref-list></back></article>
